Open Access
Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate
Cardiovascular ResearchPeer ReviewedA. I. Duenas +62008Journals
Vascular inflammation is a major atherogenic factor and Toll-like receptor (TLR) 2 ligands, including bacterial and serum lipoproteins, seem to be involved in atherogenesis. On this basis, we analysed the effect of lipoproteins and different lipid components on TLR2-dependent signalling.

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support